bearish
Shanghai Haohai Biological Technology-A
Shanghai Haohai Biological Technology (688366CH)- Diversified Business Layout Doesn't Secure Outlook
Haohai builds diversified business via M&A,but none is growth point with high certainty. Its medical aesthetics has no obvious advantage and the valuation would be lower due to centralized procurement
Equity Bottom-Up
229 Views, 19 May 2022 08:43
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- Unlimited Research Summaries
- Personalised Alerts
- Custom Watchlists
- Company Data & News
- Events & Webinars
Trusted by:
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
WHAT’S TRENDING
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Over 13 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in ...
Price Chart(Sign Up to Access)
x